Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Commission offers transparency over MDD (Medical Devices Directive) review:

This article was originally published in Clinica

Executive Summary

The European Commission will soon be posting the text of the five-year review of the Medical Devices Directive (MDD) on its website. The document will not appear on the medical device sector's website, but rather on a Commission website that publicises all documents that are being processed, once they are nearly finalised. This gives interested parties an opportunity to comment, although it is not quite certain to what extent the Commission has to take such comments into account. The review text will be published once it has received clearance, due imminently, from director and cabinet level within Directorate General Enterprise and Industry. It will then be launched for interservice consultation, giving interested directorates within the Commission an opportunity to make comments about the document.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel